These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 12023708)

  • 21. What's eating you? dusky pigmy rattlesnake envenomation and management.
    Sequeira MJ; Sequeira AJ
    Cutis; 2019 Nov; 104(5):284-287. PubMed ID: 31886787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biphasic rattlesnake venom-induced thrombocytopenia.
    Offerman SR; Barry JD; Schneir A; Clark RF
    J Emerg Med; 2003 Apr; 24(3):289-93. PubMed ID: 12676300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short-term outcomes after Fab antivenom therapy for severe crotaline snakebite.
    Lavonas EJ; Kokko J; Schaeffer TH; Mlynarchek SL; Bogdan GM; Dart RC
    Ann Emerg Med; 2011 Feb; 57(2):128-137.e3. PubMed ID: 20952098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crotalidae polyvalent immune Fab (ovine) antivenom is effective in the neutralization of South American viperidae venoms in a murine model.
    Richardson WH; Tanen DA; Tong TC; Betten DP; Carstairs SD; Williams SR; Cantrell FL; Clark RF
    Ann Emerg Med; 2005 Jun; 45(6):595-602. PubMed ID: 15940091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pygmy rattlesnake envenomation treated with Crotalidae Polyvalent Immune Fab Antivenom.
    King AM; Crim WS; Menke NB; Pizon AF
    Toxicon; 2012 Dec; 60(7):1287-9. PubMed ID: 22963729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Initial postmarketing experience with crotalidae polyvalent immune Fab for treatment of rattlesnake envenomation.
    Ruha AM; Curry SC; Beuhler M; Katz K; Brooks DE; Graeme KA; Wallace K; Gerkin R; Lovecchio F; Wax P; Selden B
    Ann Emerg Med; 2002 Jun; 39(6):609-15. PubMed ID: 12023703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized multicenter trial of crotalinae polyvalent immune Fab (ovine) antivenom for the treatment for crotaline snakebite in the United States.
    Dart RC; Seifert SA; Boyer LV; Clark RF; Hall E; McKinney P; McNally J; Kitchens CS; Curry SC; Bogdan GM; Ward SB; Porter RS
    Arch Intern Med; 2001 Sep; 161(16):2030-6. PubMed ID: 11525706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrent hemorrhage after western diamondback rattlesnake envenomation treated with crotalidae polyvalent immune fab (ovine).
    Fazelat J; Teperman SH; Touger M
    Clin Toxicol (Phila); 2008 Nov; 46(9):823-6. PubMed ID: 18608290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unpredicted late-, new-onset thrombocytopenia and hypofibrinogenemia in Fab antivenom-treated rattlesnake envenomation.
    Seifert SA; Mascarenas DN; Fullerton L; Warrick BJ; Smolinske SC
    Toxicon; 2020 Sep; 184():55-56. PubMed ID: 32505639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Late hematologic toxicity following treatment of rattlesnake envenomation with crotalidae polyvalent immune Fab antivenom.
    Ruha AM; Curry SC; Albrecht C; Riley B; Pizon A
    Toxicon; 2011 Jan; 57(1):53-9. PubMed ID: 20920516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utilisation of Crotalidae polyvalent immune fab (ovine) for Viperidae envenomations in children.
    Johnson PN; McGoodwin L; Banner W
    Emerg Med J; 2008 Dec; 25(12):793-8. PubMed ID: 19033492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of both Fab and F(ab')
    Martin AM; Wang GS; Poel K
    Am J Emerg Med; 2021 Jul; 45():677.e1-677.e3. PubMed ID: 33293188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence of immediate hypersensitivity reaction and serum sickness following administration of Crotalidae polyvalent immune Fab antivenom: a meta-analysis.
    Schaeffer TH; Khatri V; Reifler LM; Lavonas EJ
    Acad Emerg Med; 2012 Feb; 19(2):121-31. PubMed ID: 22320362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Late, new-onset thrombocytopenia in a rattlesnake envenomation treated with a Fab antivenom.
    Seifert SA; Cano DN
    Clin Toxicol (Phila); 2013 Nov; 51(9):911-2. PubMed ID: 24066732
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of F(ab')2 versus Fab antivenom for pit viper envenomation: a prospective, blinded, multicenter, randomized clinical trial.
    Bush SP; Ruha AM; Seifert SA; Morgan DL; Lewis BJ; Arnold TC; Clark RF; Meggs WJ; Toschlog EA; Borron SW; Figge GR; Sollee DR; Shirazi FM; Wolk R; de Chazal I; Quan D; García-Ubbelohde W; Alagón A; Gerkin RD; Boyer LV
    Clin Toxicol (Phila); 2015 Jan; 53(1):37-45. PubMed ID: 25361165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medically significant late bleeding after treated crotaline envenomation: a systematic review.
    Lavonas EJ; Khatri V; Daugherty C; Bucher-Bartelson B; King T; Dart RC
    Ann Emerg Med; 2014 Jan; 63(1):71-78.e1. PubMed ID: 23567063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new snake antivenom.
    Med Lett Drugs Ther; 2001 Jun; 43(1107):55-6. PubMed ID: 11426191
    [No Abstract]   [Full Text] [Related]  

  • 38. Immediate and delayed allergic reactions to Crotalidae polyvalent immune Fab (ovine) antivenom.
    Clark RF; McKinney PE; Chase PB; Walter FG
    Ann Emerg Med; 2002 Jun; 39(6):671-6. PubMed ID: 12023714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of polyvalent equine anti-viper serum to treat delayed coagulopathy due to suspected Sistrurus miliarius streckeri envenomation in two children.
    Williams KL; Woslager M; Garland SL; Barton RP; Banner W
    Clin Toxicol (Phila); 2017 Jun; 55(5):326-331. PubMed ID: 28165801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Envenomation by the Northern Blacktail Rattlesnake (Crotalus molossus molossus): case report.
    Yarema MC; Curry SC
    Pediatr Emerg Care; 2005 Jan; 21(1):40-2. PubMed ID: 15643324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.